Docosahexaenoyl glycine
Docosahexaenoyl glycine is a PUFA analogue. Docosahexaenoyl glycine has activating effects on IKs channels and restore the function of IKs channels with LQT1 mutation[1].
Product Specifications
CAS Number
[132850-40-9]
UNSPSC
12352209
Target
Endogenous Metabolite; Potassium Channel
Type
Peptides
Related Pathways
Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/docosahexaenoyl-glycine.html
Solubility
10 mM in DMSO
Smiles
O=C(O)CNC(CC/C=C/C/C=C/C/C=C/C/C=C/C/C=C/C/C=C/CC)=O
Molecular Formula
C24H35NO3
Molecular Weight
385.54
References & Citations
[1]Mark A Skarsfeldt, et al. Polyunsaturated fatty acid-derived IKs channel activators shorten the QT interval ex-vivo and in-vivo. Acta Physiol (Oxf) . 2020 Aug;229 (4) :e13471.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog